Kaan Harmankaya
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 10
- CAR-T cell therapy research 8
- Cutaneous Melanoma Detection and Management 3
- Immunology top 10%
- Immunotherapy and Immune Responses 6
- Mast cells and histamine 2
-
- Melanoma and MAPK Pathways 5
- vaccines and immunoinformatics approaches 2
-
- Drug-Induced Adverse Reactions 2
- Co-authors
- Jedd D. WolchokMichele MaioJeffrey S. WeberCélèste LebbéBart NeynsHubert PehambergerRachel HumphreyKevin M. Chin
- Journals
- Journal of Clinical Oncology (7 papers)Annals of Oncology (3 papers)American Journal of Tropical Medicine and Hygiene (1 paper)
- Partner nations
- AustriaUnited StatesItaly
In The Last Decade
Kaan Harmankaya
20 papers receiving 609 citations
Peers
Comparison fields: 5 of 46
- Oncology 522
- Immunology 318
- Pulmonary and Respiratory Medicine 105
- Genetics 28
- Molecular Biology 131
Countries citing papers authored by Kaan Harmankaya
This map shows the geographic impact of Kaan Harmankaya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaan Harmankaya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaan Harmankaya more than expected).
Fields of papers citing papers by Kaan Harmankaya
This network shows the impact of papers produced by Kaan Harmankaya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaan Harmankaya. The network helps show where Kaan Harmankaya may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kaan Harmankaya, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 0 | |
| 2 | 2014 | 118 | |
| 3 | 2014 | 60 | |
| 4 | Prediction of Metastatic Events in Patients With Cutaneous Melanoma | 2013 | 1 |
| 5 | 2013 | 139 | |
| 6 | 2013 | 24 | |
| 7 | 2013 | 18 | |
| 8 | 2013 | 3 | |
| 9 | 2012 | 12 | |
| 10 | 2012 | 19 | |
| 11 | 2012 | 3 | |
| 12 | 2010 | 23 | |
| 13 | 2010 | 83 | |
| 14 | 2010 | 7 | |
| 15 | 2009 | 5 | |
| 16 | 2009 | 2 | |
| 17 | 2009 | 6 | |
| 18 | 2008 | 28 | |
| 19 | 2008 | 22 | |
| 20 | 2008 | 32 |
About Kaan Harmankaya
Kaan Harmankaya is a scholar working on Oncology, Immunology and Ophthalmology, having authored 21 papers that have together received 622 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (10 papers), CAR-T cell therapy research (8 papers), Immunotherapy and Immune Responses (6 papers), Melanoma and MAPK Pathways (5 papers), Cutaneous Melanoma Detection and Management (3 papers), Drug-Induced Adverse Reactions (2 papers), vaccines and immunoinformatics approaches (2 papers) and Mast cells and histamine (2 papers). The work is most often cited by research in Oncology (522 citations), Immunology (318 citations) and Pulmonary and Respiratory Medicine (105 citations). Kaan Harmankaya has collaborated with scholars based in Austria, United States and Italy. Frequent co-authors include Jedd D. Wolchok, Michele Maio, Jeffrey S. Weber, Célèste Lebbé, Bart Neyns, Hubert Pehamberger, Rachel Humphrey, Kevin M. Chin, Axel Hoos and Omid Hamid. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology and American Journal of Tropical Medicine and Hygiene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.